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ABSTRACT
The synthesis of adequate amounts of ribosomes
is an essential task for the cell. It is therefore not
surprising that regulatory circuits exist to organize
the synthesis of ribosomal components. It has been
shown that defect in ribosome biogenesis (ribosomal
stress) induces apoptosis or cell cycle arrest through
activation of the tumor suppressor p53. This mecha-
nism is thought to be implicated in the pathophysiol-
ogy of a group of genetic diseases such as Diamond
Blackfan Anemia which are called ribosomopathies.
We have identified an additional response to riboso-
mal stress that includes the activation of eukaryotic
translation elongation factor 2 kinase with a conse-
quent inhibition of translation elongation. This leads
to a translational reprogramming in the cell that in-
volves the structurally defined group of messengers
called terminal oligopyrimidine (TOP) mRNAs which
encode ribosomal proteins and translation factors.
In fact, while general protein synthesis is decreased
by the impairment of elongation, TOP mRNAs are re-
cruited on polysomes causing a relative increase in
the synthesis of TOP mRNA-encoded proteins com-
pared to other proteins. Therefore, in response to
ribosomal stress, there is a change in the translation
pattern of the cell which may help restore a sufficient
level of ribosomes.
INTRODUCTION
The regulation of ribosome biogenesis is coordinated with
cell growth and proliferation throughmechanisms that have
so far only been partially elucidated. For instance, rRNA
synthesis is regulated through signaling pathways in re-
sponse to growth stimuli (1). Moreover, it is now well-
documented that signaling pathways regulate the transla-
tional activity of terminal oligopyrimidine (TOP) mRNAs
that include all vertebrate ribosomal protein (RP) mRNAs.
TOP mRNAs are relatively inefficiently translated and are
therefore referred to as ‘weak’ mRNAs. External signals
such as availability of growth factors, hormones and nu-
trients or stresses, can induce changes in the percentage of
TOP mRNAs that is associated with polysomes from 25–
45 to 60–75 and vice versa, respectively (2). Several lines
of evidence indicate that PI3K and the mTORC1 complex
are key modulators of TOP mRNAs translation after mito-
genic stimulation (3). Rapamycin, which inhibits mTORC1
by binding to mTOR in a complex with the immunophilin
FKBP12, has a variable effect on TOP mRNA translation.
In HeLa cells, it completely blocks the recruitment of TOP
messengers into polysomes following serum stimulation (2).
In other cell lines, however, this inhibitory effect is only par-
tial (3,4). The development of new, more efficient mTOR
inhibitors as well as powerful high-throughput techniques
to measure translational activity of mRNAs has recently
allowed a further clarification of the relationship between
mTORC1 and TOP mRNAs. Two laboratories reported
that translation of TOP mRNAs is specifically dependent
on mTORC1 activity (5,6). Moreover, the data of Thoreen
et al. indicate that the mTORC1 substrate 4E-BP1 is a key
player in their regulation (6), although this finding was not
confirmed in a more recent publication (7).
An important issue that remains to be explored is the
operation of regulatory mechanisms to coordinate the syn-
thesis among the many ribosomal components. It has been
shown that RPs are normally produced in larger amounts
than are needed for ribosome production, and the excess
proteins are then degraded in the nucleolus (8). Therefore,
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it is possible that coordination among ribosomal compo-
nents is achievedmainly by degradation of excessmolecules.
More recently, a number of reports have suggested that per-
turbations of ribosome biogenesis due to a variety of causes
(ribosomal stress) can activate a specific checkpoint and
block cell proliferation mostly through a p53-dependent
mechanism (9–15). This occurs, for example, in the case
of conditional deletion of RPS6 (16,17) or in response to
drugs which disrupt nucleolar structures (13,18). Interest-
ingly, Fumagalli et al. reported that impairment in the syn-
thesis of an RP induces a regulatory response that affects
the synthesis of other RPs (14). In fact, the authors ob-
served that following depletion of an RP of the small sub-
unit (RPS6, RPS7 or RPS23), TOP mRNAs are recruited
onto polysomes and, as a consequence, presumably more
actively translated.
Here, we have studied the regulatory processes which are
activated in response to defect in the synthesis of ribosomal
components. We find that the deficiency of RPS19 or other
RPs causes a slowdown of translation elongation. As a con-
sequence, there is an increase of the percentage of TOPmR-
NAs associated with polysomes. The result of this response
is that the synthesis of proteins encoded by TOP mRNAs
(which include all RPs) is maintained relative to the pro-
duction of other proteins, which is inhibited. This allows
for continued RP synthesis for new ribosome production.
MATERIALS AND METHODS
Cell culture and transient transfection
K562C and TF-1C (human erythroleukemia) cells were
maintained in RPMI 1640 medium. PC3 (human prostate
carcinoma) cells were maintained in Dulbecco’s modified
Eagle Medium. All media were supplemented with 10% fe-
tal calf serum, 50 units/ml penicillin and 50 mg/ml strep-
tomycin. TF-1C medium was also supplemented with 5
ng/ml Granulocyte-Macrophage Colony-Stimulating Fac-
tor. Cells were incubated at 37◦C in a humidified atmo-
sphere with 5% CO2. TF-1C and K562C cells, express-
ing inducible siRNA targeting RPS19 mRNA, were pre-
pared in Karlsson’s laboratory (19). Expression of siRNA
was induced by adding 2 g/ml of doxycycline for four
days. PC3 cells (5 × 106) were transiently transfected
with 100 nM siRNA and 10 l of Interferin transfec-
tion reagent (Polyplus transfection) according to the man-
ufacturer’s protocol. After 48 h, they were harvested
and analyzed by polysomal gradient assay or by western
blot. The siRNA target sequences were as follows: sense
5′-UAUUUAAGGGCUUUCUUAC-3′ for human RPS6,
sense 5′-GAUGGCAGCCGGCUCAUAA-3′ for human
RPS7, sense 5′-GAGAUCUGGACAGAAUCGC-3′ for
RPS19, sense 5′-GGUGCGGGAGUAUGAGUUA-3′ for
RPL11 and sense- 5′-GACACGCGACUUGUACCAC-3′
for control siRNA (siCNT).
K562C cells were treated with 50 ng/ml cycloheximide
(Sigma-Aldrich) for 1 h and PC3 cells with 25 nM actino-
mycin D (Sigma-Aldrich) for 12 h. Both K562C and PC3
cells were treated with 1MPP242 (Sigma-Aldrich) for 2 h.
Cap-affinity chromatography
For the isolation of eIF4E (cap)-associated proteins, K562C
and PC3 cells were lysed in buffer (containing 50 mM
Hepes, 75 mM NaCl, 10 mM MgCl2, 1 mM DTT, 8 mM
EGTA, 10mM-glycerophosphate, 0.5mMNa3VO4, 0.5%
Triton-X-100 and protease inhibitor cocktail). Cell extracts
were incubated for 10 min on ice and centrifuged at 16 000
g for 10 min at 4◦C. The supernatant was collected, pro-
tein was quantified by the Bradford assay and 0.5 mg of
protein extracts was diluted in 0.5 ml of lysis buffer and
incubated with 10 l of m7GTP-sepharose (GE Health-
care) plus 10 l of Sepharose CL-4B (GE Healthcare) at
4◦C for 90 min under constant shaking. After centrifuga-
tion for 30 s at 2500 g, beads were washed three times with
lysis buffer, resuspended in Laemmli buffer and subjected
to western blot analysis. Blots were decorated with antibod-
ies against eIF4E (Cell Signaling), eIF4G (Cell Signaling),
4E-BP1, RPS19 (monoclonal (20)) or rabbit polyclonal -
tubulin (Santa Cruz).
Protein analysis
To prepare protein total extracts, cells were washed in
phosphate-buffered saline (PBS) and lysed in high-salt ly-
sis buffer (50 mM Tris-HCl pH 7.5, 350 mM NaCl, 1 mM
MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 1% Nonidet P-
40, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pep-
statinA, 100 mg/ml PMSF). After 30 min on ice, nuclei and
other organelles were collected by centrifugation at 16 000
g for 15 min. The supernatant was transferred into a new
tube and protein concentrations were determined using the
Bradford assay.
Proteins were separated on sodium dodecyl sulfate (SDS)
polyacrylamide gels containing 12% acrylamide, trans-
ferred onto nitrocellulose Protran membrane (Schleicher
and Schuell) and incubated with the following primary an-
tibodies: rabbit monoclonal antibody specific for p70S6K1
(Upstate), rabbit polyclonal for phospho-p70S6K1 specific
for threonine 389 (Santa Cruz), 4E-BP1 (kindly provided
by Nahum Sonenberg, Montre´al, Canada), mouse mon-
oclonal anti-RPS19 (20), rabbit polyclonal specific for -
tubulin (Santa Cruz), rabbit anti--actin (Sigma-Aldrich),
rabbit polyclonal anti-eEF2 (Cell Signaling), rabbit poly-
clonal anti-phospho-eEF2 antibody specific for threo-
nine 56 (custom made by Eurogentec). Primary antibod-
ies were revealed using horseradish peroxidase-conjugated
goat anti-rabbit or anti-mouse Ab (Jackson Immunore-
search) and the ECL chemiluminescence detection sys-
tem (Pierce). Quantification analyses were performed by
LAS3000 Image System (Fuji) and ImageQuant software
(GE Healthcare).
Protein labeling
For general protein synthesis, 2 × 105 K562C or PC3 cells
were incubated for 30 min with [35S] methionine/cysteine
(PRO-MIX, GE Healthcare, >1000 Ci/mmol) to a final
concentration of 10 Ci/ml. Cells were lysed in PBS–SDS
buffer (150 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.4
mM KH2PO4 and 0.1% SDS) and proteins were precipi-
tated in 10% (w/v) trichloroacetic acid (TCA). After three
12670 Nucleic Acids Research, 2014, Vol. 42, No. 20
washes with 5% (w/v) cold TCA, the insoluble material was
collected on GFC filters (Whatman) and the incorporated
radioactivity was measured in scintillation counting.
For immunoprecipitation, PC3 cells (4 × 106) or K562C
(15 × 106) were incubated in 2.5 or 5 ml of methionine-
and cysteine-free medium supplemented with 10% dialyzed
FBS and containing [35S]methionine/cysteine (PRO-MIX,
GEHealthcare,>1000Ci/mmol) to a final concentration of
300 Ci/ml for 30 min at 37◦C. The labeling medium was
removed, and the cells were washed once in PBS, frozen in
liquid nitrogen and stored at −70◦C to be analyzed later or
immediately processed.
Immunoprecipitation
Radiolabeled PC3 or K562C cells were lysed in buffer with
detergent (25 mM HEPES pH 7.6, 100 mM NaCl, 0.5%
Nonidet P-40, 0.1 mM EDTA, 10% glycerol, 1 mM DTT,
protease inhibitor cocktail). Lysates were incubatedwith ro-
tation at 4◦C for 10 min and nuclei and other organelles
were removed by centrifugation at 13 000 g for 15 min at
4 ◦C. Equal amounts of protein (1–2 mg) were precleared
by incubation with 15–30 l of magnetic beads (Dynabeads
Protein G -Millipore) for 45 min at 4◦C. Subsequently, the
supernatant was incubated with 8 g of anti-eEF1A (Milli-
pore) or 4 g of anti-SOD1 (Millipore) overnight at 4◦C
under agitation. The extracts were then incubated for 60
min with 50 l of Dynabeads Protein G. The immunocom-
plexes were isolated by a magnetic support and washed five
timeswith 500l of lysis buffer. Proteins bound to the beads
were eluted in SDS-PAGE sample buffer and heated at 90◦C
for 10 min. Immunoprecipitated proteins were separated on
4–12% NuPAGE Bis-Tris gel (Invitrogen) and electroblot-
ted onto nitrocellulose (Protran; Schleicher and Schuell).
Newly synthesized proteins were detected by exposing the
membrane to a Phosphorimager screen at room tempera-
ture for 16 h; while total protein was detected by incubating
with antibody against EF1A or SOD. Band intensities were
quantified by densitometry usingwith the ImageQuant soft-
ware (GE Healthcare).
Polysomal RNA analysis
K562C, TF-1C and PC3 cells (1–2 × 106) were washed
once with PBS buffer (150 mM NaCl, 2.7 mM KCl, 8 mM
NaH2PO4 and 1.4 mM K2PO4), lysed with 300 l of ly-
sis buffer (10 mM NaCl, 10 mM MgCl2, 10 mM Tris-
HCl pH 7.5, 1% triton-X100, 1% sodium deoxycholate,
36 U/ml RNase inhibitor (Promega), 1 mM dithiothreitol)
and transferred into a microcentrifuge tube. After 2 min
of centrifugation at 16 000 g at 4◦C, the supernatant was
frozen in liquid nitrogen and stored at−70◦C to be analyzed
later, or immediately layered onto a 15–50% (w/v) sucrose
gradient (containing 30 mM Tris-HCl pH 7.5, 100 mM
NaCl and 10 mM MgCl2) and centrifuged in a Beckman
SW41 rotor for 110 min at 170 000 g. Fractions were col-
lected while monitoring the optical density at 254 nm. RNA
was extracted from each polysomal fraction, from cells and
from the only cytoplasmic compartment by the proteinase
K method. For northern analysis, RNA was fractionated
on formaldehyde-agarose gels and transferred to Gene-
Screen Plus membrane (PerkinElmer Life Sciences). North-
ern blotting was performed essentially as recommended by
the manufacturer. Radioactive probes were prepared by the
random primer technique using DNA fragments isolated
fromplasmids containing PCR-amplified cDNA sequences.
Quantitation of northern blot filters was done with a Phos-
phorImager (GE Healthcare).
Ribosome transit time mesaurements
K562C cells (3 × 107) were suspended in 5 ml of label-
ing medium (RPMI 1640 supplemented with 10% dialyzed
bovine calf serum, 3.5 g glucose/l and 2 mM glutamine)
for 20 min and then 12 Ci/ml [35S]methionine/cysteine
cell labeling mix (PRO-MIX) was added. At the times in-
dicated, cells were harvested, pelleted and resuspended in
0.5 ml of RSB (10 mM NaCl, 10 mM Tris-HCl at pH
7.4, 15 mM MgCl2 and 100 g/ml heparin). Cells were
lysed by adding 70 l of lysis buffer (10% Triton X-100,
10% deoxycholate), rapidly mixed and incubated few min
in ice. Nuclei and mitochondria were pelleted by centrifu-
gation for 10 min at maximum speed in a microfuge at 4◦C.
Five hundred microliter of the PMS (post-mitochondrial
supernatant) was mixed with an equal volume of polyso-
mal buffer (25 mM Tris-HCl at pH 7.4, 10 mM MgCl2, 25
mMNaCl, 0.05% Triton X-100, 0.14M sucrose, 500 g/ml
heparin), and 450l was removed tomeasure incorporation
of [35S]-methionine and -cysteine into total protein (nascent
and completed). Polysomes were pelleted by centrifugation
of the remaining supernatant at 100 000 g for 20 min at
4◦C in a Beckman 70.1Ti rotor. Four hundred and fifty mi-
croliter of post-ribosomal supernatant (PRS) was removed
to measure the incorporation of [35S]-methionine/cysteine
into completed proteins. PMS and PRS samples weremixed
with equal volumes of 20% TCA containing 10 mM each
of methionine and cysteine, placed in ice for 20 min and
then TCA precipitates were collected on a glass fiber filter
(GF/C; Whatman). Filters were washed with ice-cold 10%
TCA, rinsed once with ethanol and air dried before being
subjected to liquid scintillation counting.
RESULTS
Ribosomal stress causes recruitment of TOP mRNA on
polysomes
To investigate the translational efficiency of TOP mRNAs
in response to the depletion ofRPS19, we used twomodified
cell lines, K562C and TF-1C, both infected with a lentivi-
ral vector which allows doxycycline (dox)-inducible expres-
sion of siRNA specific for the RPS19mRNA (19). To assess
the amount of TOPmRNA associated with polysomes dur-
ing the induction of RPS19 deficiency, cytoplasmic extracts
from K562C and TF-1C cells (untreated or treated for four
days with dox) were separated on sucrose gradients. Frac-
tions were collected and analyzed by northern blot. Con-
sistent with the findings of other laboratories (14,21), we
observed an increase of polysomal association of the TOP
mRNAsRPS19, RPS6, RPL7a, eEF1A (inK562C and TF-
1C), RPL11 (only in TF-1C), in RPS19-depleted cells (Fig-
ure 1a and b). To rule out an effect of dox itself, we used a
K562 cell line infected with a lentiviral vector inducible for
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Figure 1. Polysomal association of TOP mRNAs during ribosomal stress. (a) Cytoplasmic extracts from K562C cells untreated (-dox) or treated for four
days with doxycycline (+dox) were separated on sucrose gradients. Fractions were collected and polysomal profiles were obtained while monitoring the
optical density at 260 nm (last panel). RNA extracted from each fraction was analyzed on northern blots with probes for the TOP mRNAs RPS6 (S6),
RPS19 (S19), RPL7a (L7a) and eIF1A or -actin (as a non-TOP control). Quantification of the signals is reported as a linear plot of the percentage of
mRNA in each fraction. (b) Experiments performed in TF-1C cells as in (a). Quantification is shown as a bar graph of the percentage of messenger (mRNA)
associated with polysomes (fractions 1–5). Values represent the mean ± S.E. of at least three independent experiments. (c) Cytoplasmic extracts from PC3
cells transfected with a control siRNA (siCNT) or siRNAs against RPS6 (siS6) or RPL11 (siL11) were analyzed as in (a) with probe specific for the TOP
mRNA RPS19 (S19), RPL7a (L7a) and RPL11 (L11). (d) Cytoplasmic extracts from PC3 cells treated for 12 h with low doses (25 nM) of actinomycin D
(ActD) were analyzed as in (c).
the expression of control siRNA (iSCR). In this case, dox
treatment did not cause any change in the polysomal asso-
ciation of TOP mRNAs (Supplementary Figure S1a). As a
further control, to verify that RPS19 depletion did not alter
TOP mRNA turnover or subcellular localization, we ana-
lyzed total, nuclear and cytoplasmic mRNA levels in con-
trol and dox-induced K562C cells. The results confirmed
that TOP mRNA level did not change following RPS19 de-
pletion (Supplementary Figure S1b).
To test if TOP mRNA recruitment could be observed in
other cell types after depletion of other RPs, we used the
prostate cancer cell line PC3. In this case we carried out
transient transfection of specific siRNAs to induce the de-
pletion of RPS6 (siRPS6), RPL11 (siRPL11) and an unre-
lated siRNA as a control (siCNT). The association of se-
lected TOP mRNAs with polysomes was analyzed as de-
scribed above, and the results, reported as column graphs in
Figure 1c, indicate that depletion of RPS6 or RPL11 causes
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an increase of the percentage of TOP mRNAs (RPS19,
RPL7a, RPL11) associated with polysomes.
Finally, to analyze the effect of ribosomal stress caused
by another mechanism, we treated PC3 cells with low doses
of actinomycin D (actD), which is known to inhibit rRNA
transcription. Analysis of polysomal association of TOP
mRNAs, shown in Figure 1d, indicates that actD treatment
increases the levels of the RPS6 and RPL7a mRNAs which
are associated with polysomes.
Ribosomal stress does not affect mTORC1 and ERK signal-
ing but inhibits general protein synthesis
To assess possible changes in known signaling pathways, we
analyzed the phosphorylation status of themTORC1down-
stream targets S6K1 and 4E-BP1. As a control, we treated
cells with the mTOR inhibitor PP242 which is known to
abolish 4E-BP1 phosphorylation. As shown in Figure 2a
and b, western analysis indicated that RPS19 depletion in
K562C or PC3 cells did not increase the phosphorylation of
S6K or 4E-BP1. We also analyzed the phosphorylation sta-
tus of ERKkinase observing no alteration caused byRPS19
depletion in K562 cells (Figure 2c). As an additional analy-
sis of the translation efficiency in RPS19-depleted cells, we
monitored the assembly of the eEF4F initiation complex
by pull-down assays with 7-methyl-GTP-Sepharose beads
(Figure 2d). Consistent with the data on 4E-BP1 phospho-
rylation, we observed that RPS19 depletion did not change
the relative amounts of eIF4G and 4E-BP1 associated with
eIF4E (and therefore retained on the beads). These data
are consistent with a report by Zinzalla et al. that observed
no effect of ribosomal stress on mTORC1 after depletion
of RPL7 in HeLa cells (22). However, it should be men-
tioned that a mild activation of mTORC1 was observed in
zebrafish after depletion of RPS14 or RPS19 (23).
To further analyze the effect of RPS19 depletion, wemea-
sured general protein synthesis. For this purpose K562C
cells, untreated or treated with dox, or PC3 cells transfected
with siRNA specific forRPS19, were labeled for 30minwith
a mixture of [35S]methionine/[35S]cysteine. The amount of
[35S] incorporated into newly synthesized proteins, reported
as a column graph in Figure 2e, indicates that RPS19 de-
pletion causes a reduction of general protein synthesis both
in K562C cells (down to 60% of control), and in siRNA-
treated PC3 cells (70% of control). Thus, as anticipated, in-
terfering with ribosome biogenesis does indeed impair over-
all protein synthesis. Although depletion of an RP causes a
decrease in the amount of ribosomes in the cell, we think
that this is not the direct cause of the reduction of pro-
tein synthesis. In fact, the analysis of absorbance profiles of
RP-depleted cells shows a decrease of ribosomal subunits
(40S or 60S according to the depleted RP) and 80S par-
ticles whereas the amount of polysomes does not change
(Supplementary Figure S2a and b). To gain a more quanti-
tative measure of this observation, we used a probe specific
for 18S rRNA to evaluate the amount of ribosomes present
in the different fractions of a sucrose gradient. The results
indicate that in RPS19-depleted PC3 cells, total 18S rRNA
per microgram of total protein is reduced to ∼70% and this
is similar to the decrease of RPS19 measured on western
blot (Supplementary Figure S2c). However, the amount of
18S rRNA in the polysomal fractions shows only a minimal
reduction (5% decrease) indicating that the amount of ribo-
somes engaged in protein synthesis does not change (Sup-
plementary Figure S2c).
Protein synthesis is inhibited at the elongation level
Absorbance profiles of RP-depled cells (Figure 1) did not
show a decrease in the average polysome size suggesting
that initiation was not impaired. Therefore to explain the
decrease in protein synthesis, we examined the translation
elongation rate by analyzing the ribosome transit time (24).
This was performed by measuring the kinetics of radioac-
tive amino acid incorporation into total protein in PMS and
into completed polypeptides released from ribosomes into
PRS (Figure 3a). The average half-transit time was deter-
mined from the displacement in time between the two lines
corresponding to the PMS and PRS data plotted as a func-
tion of time (explained in Supplementary Figure S3), and
was calculated to be 53 and 96 s, for control and dox-treated
K562C cells, respectively. These data, shown in the column
graph of Figure 3b, indicate that RPS19 depletion slows
elongation by ∼50%. The fact that the lines of the plots
are not parallel probably reflects incomplete recovery of re-
leased labeled polypeptides (PRS) in the supernatant, likely
because some of the new polypeptides are associated with
entities that are in the pellet (e.g. ribosomes, organelles).
Similar profiles are shown in a number of published reports
(25,26). Although the non-parallel nature of the plot might
affect the precision of the measurements, it does not change
the overall conclusion that elongation rates are altered.
To study further the elongation rates using a different
method, we analyzed the kinetics of ribosome run-off from
polysomes after inhibition of translation initiation. For
this purpose PC3 cells, transfected with control or RPS19-
specific siRNA, were treated with 2g/ml of harringtonine,
which blocks initiation by inhibiting the first round of elon-
gation (27), and polysome analyses were performed at dif-
ferent times. As shown in Figure 3c and Supplementary Fig-
ure S4, the TOP mRNAs for eEF1A (28), RPL4 and RPS7
shift gradually out of polysomes more slowly in RPS19-
depleted (siRPS19) cells compared to the control (siCNT).
The same analysis on the control -actin mRNA showed a
similar behavior (Figure 3c and Supplementary Figure S4).
This confirms (i) that elongation rates are indeed slower in
RPS19-depleted cells and (ii) that such rates are likely sim-
ilar for TOP and non-TOP mRNAs. This effect on elonga-
tion is rather unexpected, as deficiency of a ribosomal sub-
unit would be expected to affect initiation. We think that
this is a specific mechanism to maintain homeostatic equi-
librium in ribosome synthesis (see discussion).
Pharmacological inhibition of elongation causes a recruit-
ment of TOP mRNA on polysomes
It has long been known that partial inhibition of translation
elongation can actually increase the polysomal association
of mRNAs that exhibit a low intrinsic initiation efficiency
(29). The relatively poor initiation efficiency of TOP mR-
NAs, compared to other housekeeping mRNAs, was noted
in the initial molecular analyses (30,31). In fact, the per-
centage of TOP mRNA associated with polysomes ranges


























































































































Figure 2. Analysis of mTORC1 pathway and protein synthesis. (a) Protein extracts, prepared from K562C cells treated with or without dox and from PC3
cells transfected with an unrelated siRNA (siCNT) or with a siRNA against RPS19 (siS19), were analyzed by western blot with the indicated antibodies.
(b) The same extracts plus samples from cells treated with the mTOR kinase inhibitor PP242 (1M) were analyzed to distinguish different phosphorylated
forms of 4E-BP1. Small arrows indicate the different phosphorylation forms of 4E-BP1 and an unspecific signal is indicated by asterisk. PP242 lane of PC3
extracts is from the same gel. (c) Same as in (a). (d) K562C and PC3 cells treated as in (a) were subjected to cap-column pull-down assay using 7-methyl-GTP
Sepharose beads. Cell lysates (input) or proteins bound to m7GTP-Sepharose (m7G) were analyzed by immunoblotting using indicated antibodies. PP242
lane is from a different gel. (e) K562C and PC3 cells treated as in (a) were incubated with [35S]-met/cys mix for 30 min. [35S]-amino acid incorporation
was measured by scintillation counting and the cpm (counts per minute) obtained were normalized to the total amounts of protein. Results are shown as
a bar graph considering control cells as 100% and represent the mean ± S.E. of three independent experiments.
from 25 to 70 in different cell types and growth conditions,
whereas the polysomal proportion of other housekeeping
mRNAs (e.g. actin) is always higher and varies from 70%
to >90% (2,31,32). To address the effect of elongation in-
hibition on the polysomal association of TOP mRNAs, we
treatedK562C cells with lowdoses (50 ng/ml) of the elonga-
tion inhibitor cycloheximide for 1 h. This treatment causes
an inhibition of [35S]met/cys incorporation to∼35%of con-
trols (Figure 4b) and induces a recruitment of free ribo-
somal subunits into polysomes (Figure 4a, last panel). We
measured the amount of RPS6, RPS7, RPL11 and -actin
mRNAs associated with polysomes as above. The results
are shown as a linear graph of the percentage of mRNA in
the different fractions (Figure 4a). Consistent with the hy-
pothesis that slowing elongation augments the polysomal
association of poorly initiating (‘weak’) mRNAs, cyclohex-
imide treatment caused a recruitment of TOP mRNAs into
polysomes. The effect is evident for the ‘weak’ TOP mR-
NAs (from 20–40% to 60–70% on polysome) but is barely
observed for the ‘strong’ -actin mRNA.
The synthesis of the TOP mRNA-encoded eIF1A does not
change during ribosomal stress
The observed increase in the polysomal association of TOP
mRNAs in response to ribosomal stress is, therefore, con-
sistent with an inhibition of translation elongation favor-
ing the accumulation of ribosomes on weak mRNAs. Im-
portantly, this effect could favor the synthesis of, e.g. RPs,
relative to general protein synthesis in the face of inade-
quate RP availability, in effect helping to maintain ribo-
some production. To assess this idea, we induced RPS19
depletion in PC3 cells and, after 30 min labeling with a
[35S]Met/Cys, we analyzed: (i) overall protein synthesis
rates (Figure 5a); (ii) the percentages of eEF1AmRNA (ex-
ample of a TOP mRNA) and SOD mRNA (non-TOP) as-
sociated with polysomes (Figure 5b) and (iii) quantitation
of newly synthesized eEF1A and SOD by specific immuno-
precipitation followed by quantitation of the associated ra-
diolabel (Figure 5c and d). For this purpose, the immuno-
precipitated complexes were separated on SDS-PAGE and
transferred onto nitrocellulose membranes. We then mea-
sured both radiolabeled protein (by direct exposure of the
membrane) and total protein (by immunoblot quantitation;
Figure 5c). The results are reported graphically as the ra-
tio of [35S]labeled:total protein (Figure 5d). eEF1A was
selected because it is encoded by a well-established TOP
mRNA and studying eEF1A obviated various problems en-
countered in attempts to immunoprecipitate ribosomes. In
this experiment, PC3 cells (untransfected, transfected with
control siRNA, or with siRNA specific for RPS19) were
serum-starved for ∼16 h and then an aliquot of untrans-
fected cells was stimulated with serum for 1 h. Serum stimu-
lation after starvationwas used as a control since it is known
to promote polysomal loading of TOP mRNAs mainly as a











































































































Figure 3. Analysis of translation elongation. (a) Ribosome transit time measurements in K562C cells, either untreated (-dox) or treated for four days
with dox (+dox), were determined by measuring the kinetics of [35S]-methionine/[35S]-cysteine incorporation into total protein in PMS and PRS. The
radioactivity at each time point is presented as a mean ± S.E. of three independent experiments. The transit time was obtained from the displacement in
time between the intercepts of the two lines on the time axis, which were determined by linear regression analysis. (b) Means ± S.E. of three independent
experiments. * Student t-test P < 0.05. (c) Cytoplasmic extracts from PC3 cells transfected with a control siRNA (siCNT) or with siRNA against RPS19
(siS19) untreated (T= 0’) or treated for 5 and 10 min with harringtonine (T= 5’, T= 10’) were separated on sucrose gradients and analyzed as in Figure 1.
consequence of regulation of initiation of their translation
(2).
The results indicate that: (i) serum stimulation caused a
modest upregulation of general protein synthesis whereas
RPS19 depletion induced a slight decrease (Figure 5a). (ii)
As expected from earlier studies (28,33), the percentage of
the eEF1AmRNA associated with polysomes increased af-
ter serum stimulation. A similar increase occurs following
depletion of RPS19, as also shown in Figure 1. In con-
trast, the polysomal association of the SOD mRNA was
barely affected either by serum stimulation or RPS19 de-
pletion. (iii) Notably, the ratio [35S]-labeled:total eEF1A
increases during serum stimulation and is not altered by
RPS19 depletion, whereas the ratio [35S]:total SOD in-
creases slightly during serum stimulation and reproducibly
decreases during RPS19 depletion. Similar results were ob-
tained in K562C cells where, when RPS19 was depleted,
the ratio [35S]:total SOD showed a more evident decrease
compared to the [35S]:total eEF1A ratio (Figure 5e and f).
These data show that the production of eEF1A (encoded by
a prototypical TOP mRNA) is preserved during ribosomal
Nucleic Acids Research, 2014, Vol. 42, No. 20 12675
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Figure 4. Polysomal association of TOP mRNAs during cycloheximide treatment. (a) Cytoplasmic extracts from K562C cells untreated (-chx) or treated
(+chx) with cycloheximide (50 ng/ml) for 1 h were separated on sucrose gradients and analyzed as in Figure 1. (b) K562C cells treated with different
concentration of cycloheximide (chx) were incubated with [35S]-met/cys mix for 30 min. [35S] incorporation was measured by scintillation counting and
results are shown as a bar graph of the means ± S.E. of three experiments.
stress relative to the synthesis of SOD (not coded by a TOP
mRNA), which is impaired.
RP depletion induces activation of eEF2K and eEF2 phos-
phorylation
The phosphorylation of eEF2 inhibits translation elonga-
tion (34). Thus, to examine the mechanism by which elon-
gation is inhibited in RPS19-depleted cells, we analyzed the
phosphorylation status of eEF2 in K562C and PC3 cells.
The results (Figure 6a and b) indicate that, consistent with
an inhibition of elongation, the level of phosphorylated
eEF2 (Thr56) increases by ∼2.5-fold in RPS19-depleted
K562C cells and in PC3 cells after depletion of RPS6, RPS7
or RPS19. The enzyme that phosphorylates eEF2 on the
regulatory site (Thr56) is eEF2 kinase (eEF2K). We tested
the activity of eEF2K in K562 cells following induction of
RPS19 depletion. We performed an in vitro kinase assay
using dox-treated K562C cell extracts using eEF2 as sub-
strate. The data (Figure 6c) show that eEF2K is more active
following RPS19 knock-down suggesting it is its activation
that leads to the increased phosphorylation of eEF2.
Then, we used an HCT116 cell line in which depletion of
eEF2K can be induced by IPTG treatment. We observed
that inhibition of expression of eEF2K abolished the in-
crease of phospho-eEF2 induced by RPS19 depletion (Fig-
ure 6d), indicating that eEF2K is indeed responsible for the
phosphorylation of eEF2 in this setting.
Finally, it has been shown that eEF2K is inhibited by
phosphorylation on Ser366 (35). To further address the ac-
tivity of the kinase during ribosomal stress, we used anti-
bodies specific for the phosphorylated form (Ser 366) of the
protein. Western analysis, reported in Figure 6e, shows that
RPS19 depletion in K562 cells causes decreased phospho-
rylation of eEF2K on Ser366, consistent with the observed
enhancement its kinase activity.
DISCUSSION
We report here a previously uncharacterized response to de-
fects in ribosome biosynthesis that involves translational re-
programming dependent on inhibition of translation elon-
gation. We find that depletion of an RP, or administra-
tion of low doses of actinomycin D, induces an increase
in the proportion of TOP mRNAs that are associated with
polysomes. This can be observed both in p53-positive (14)
and p53-negative cells (our data), suggesting that this tu-
mor suppressor does not play a role in the phenomenon.
It has been known for a long time that the polysomal as-
sociation of TOP mRNA correlates with the growth sta-






































































































































Figure 5. Analysis of newly synthesized eEF1A and SOD. (a) PC3 cells
untransfected (−FBS, +FBS), transfected with a control siRNA (siCNT)
or with siRNA against RPS19 (siS19), were grown without serum for 16 h.
An aliquot of untransfected cells was stimulated with serum for 1 h (+FBS)
prior to analysis. Cells were radiolabeled with [35S]met/[35S]cys mix for 30
min and analyzed by scintillation counting. Values (cpm) were normalized
to protein amount and the means± S.E. of three independent experiments
are shown as a bar graph considering −FBS and siCNT cells as 100. (b)
Portions of the samples described in (a) were subjected to polysome asso-
ciation analysis as described in Figure 1. The percentages of eEF1A and
SOD mRNAs associated with polysomes are reported as a bar graph. (c)
Part of the samples described in (a) (equal amount of proteins) was im-
munoprecipitated with antibodies against eEF1A or SOD, separated on
SDS-PAGE and subjected to western blot. Radiolabeled eEF1A and SOD
were detected by direct exposure of the membrane to phosphor screens
(35S). Total eEF1A and SOD in immunoprecipitates (IP) were detected
with specific antibodies (IB). (d) Quantification of radiolabeled/total pro-
tein ratios ([35S]/immunoblot; IB) of experiment c. Ratios of siS19 cells are
the mean ± S.E. of at least three gels from two independent experiments.
Student’s t test (*P = 0.01). (e) K562C cells +/− dox were analyzed as in
(c). (f) Quantitative analysis of (e), means of three experiments ± S.E.
tus of the cell (36). The recruitment of TOP mRNAs onto
polysomes in response to (ribosomal) stress was therefore
unexpected, considering that it was occurring in parallel to
protein synthesis inhibition and impaired cell growth. We
hypothesized that this could be the consequence of a mech-
anism for achieving homeostasis in ribosome biosynthesis,
whereby a defect in ribosome synthesis induces a compen-
satory increase of RP synthesis. A similar regulation has
been already observed during the development of the Xeno-
pus ‘anucleolate’ mutant (37) and in cultured Xenopus cells
treated with transcriptional inhibitors (38). However, the
mechanism underlying those responses was not explored.
For this reason, we started to address the response to ri-
bosomal stress by measuring the activity of the mTORC1
pathway since it is implicated in the translational regulation
of TOP mRNAs (reviewed in (36)). Analysis of the phos-
phorylation of the direct mTORC1 targets S6K1 and 4E-
BP1 indicated that the activity of mTORC1, at least in our
cellular models (K562C and PC3 cells), was not affected by
ribosomal stress. In addition, general protein synthesismea-
sured by metabolic labeling was reduced in RPS19-depleted
K562C and PC3 cells. To analyze the decrease in transla-
tional activity, we then used a classical assay to measure
elongation rate (ribosome transit time) and employed a new
method to measure ribosome run-off times after inhibition
of translation initiation. The results indicate that, consistent
with the reduction in protein synthesis, although polysome
size is preserved, the induction of ribosomal stress inK562C
cells caused a decrease in the average velocity of ribosomes
in translating the mRNA, i.e. it impaired the rate of elon-
gation. This finding was supported by the observation that
the level of the inhibitory phosphorylation of eEF2 (Thr56)
increased more than 2-fold in RPS19-depleted K562C cells
and in PC3 cells after depletion of RPS6 orRPS7 orRPS19.
The picture emerging from our analysis was, therefore, that
the recruitment of TOP mRNAs in polysomes in response
to ribosomal stress was not due to a specific stimulatory
effect (e.g. on mTORC1) but rather to a general slowing
down of translation elongation. In fact, it has been shown
that mRNAs can be translated according to their capacity
to compete for a limiting component of translation initi-
ation (29,39), where ‘weak’ mRNAs compete inefficiently.
Specific partial inhibition of elongation can make it, rather
than initiation, the rate-limiting step of translation. Conse-
quently, competition at the initiation stage is alleviated and
the polysomal association of inefficient (‘weak’) mRNAs
increases. Consistent with this model, treatment of K562C
cells with a low dose of the elongation inhibitor cyclohex-
imide also increased the percentage of TOP mRNAs asso-
ciated with polysomes.
At this point, our data indicated that RPS19 depletion
caused: (i) a 25–30% decrease of general protein synthesis,
(ii) a 20–30% increase in the amount of TOP mRNAs as-
sociated to polysomes and (iii) a 50% decrease in elonga-
tion rate (in K562C cells). One interpretation of these find-
ings was that the increase in polysome-associated TOPmR-
NAs could partly compensate the inhibition of elongation,
allowing cells to preserve the synthesis of TOP mRNA-
encoded proteins even when synthesis of other cellular pro-
teins is impaired. To validate this hypothesis, we induced
ribosomal stress in PC3 cells and measured (i) polysomal
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Figure 6. Analysis eEF2 and eEF2Kduring ribosomal stress. (a) Protein extracts fromK562C cells were analyzed as in Figure 2awith the indicated primary
antibodies. Phospho-eEF2/eEF2 ratio is reported on the right with untreated sample set as 1 (mean ± S.E. of at least three independent experiments). (b)
PC3 cells were transfected with a control siRNA (siCNT) or with siRNAs against RPS6 (siS6), RPS7 (siS7) and RPS19 (siS19). Proteins were analyzed as
in (a). (c) Protein extracts from K562C cells +/− dox were incubated with recombinant eEF2, [ -32P]ATP and Ca2+/CaM. Samples were then analyzed
by SDS-PAGE and autoradiography (AR) or western blot (WB). Extracts treated with PP242 were used as control. The space between lanes denotes that
these are non-adjacent lanes from the same gel. (d) HCT116 cells treated with IPTG 1 mM to induce eEF2K knock-down were transfected with siRNA
against RPS19 (siS19). Proteins were analyzed by western blot with the indicated antibodies. Quantification is reported on the right as in (a). (e) Protein
extracts from K562C cells were analyzed as in (a) with the indicated primary antibodies. The phospho-eEF2K/eEF2K ratio is reported on the right with
untreated sample as 1 (mean ± S.E. of at least three independent experiments).
association of a well-established TOP mRNA (eEF1A) and
a non-TOP mRNA (SOD) and (ii) the synthesis of the pro-
teins encoded by suchmRNAs.We found that the increased
polysomal association of the eEF1AmRNA during RPS19
depletion did not lead to the synthesis of more eEF1A pro-
tein (which is observed following serum stimulation). How-
ever, increased polysomal association of its mRNA does
‘protect’ its synthesis from the inhibition observed for gen-
eral protein synthesis and, e.g. for a protein (SOD) that is
not encoded by a TOP mRNA.
Our data suggest that the inhibitory response to riboso-
mal stress at the level of protein synthesis is mediated by ac-
tivation of eEF2K and phosphorylation of eEF2 on Thr56.
eEF2K is a regulator of translation that has been shown
to mediate cell survival in response to nutrient deprivation
(40). The activity of eEF2K is inhibited by phosphoryla-
tion on Ser366 catalyzed by S6K1 and p90RSK (35). We ob-
served that ribosomal stress causes decreased phosphoryla-
tion of eEF2K at Ser366. This is consistent with the increase
of phospho-eEF2 and the inhibition of translation elonga-
tion that we detected in our experimental conditions. The
mTORC1 pathway, which by activating S6K1 would be a
prime candidate for the regulation of eEF2K activity, did
not show any change during ribosomal stress, similarly to
what has been observed in HeLa cells after depletion of L7
(22). ERK phosphorylation is also unaffected, making un-
likely a role of p90RSK in eEF2K regulation.
In any case, we hypothesize that there is some kind of
‘sensor’ that ascertains whether the level of ribosomes is suf-
ficient for the cellular needs and, in case of deficiency, would
induce derepression of eEF2K and a consequent phospho-
rylation of eEF2. A potential candidate for this role is the
mTORC2 complex, that has been recently shown to asso-
ciate with ribosomes and to be involved in the response to
ribosomal stress (22,41). One study (41) reported that inhi-
bition of mTORC2 causes an increase of eEF2 phospho-
rylation, indicating that it may regulate either the kinase
and/or phosphatase specific for this elongation factor. An-
other potential sensor of ribosomal stress is the protein ki-
nase PIM1, which has been shown to interact with ribo-
somes and it is destabilized by ribosomal stress (42). The
decrease in PIM1 level during ribosomal stress could cause,
directly or indirectly, the activation of eEF2K.This possibil-
ity, however, remains to be addressed and othermechanisms
could also be hypothesized.
Independently of the specific mechanism, our data re-
veal a novel regulatory circuit that could be interpreted as
a homeostatic control of ribosome biogenesis. In fact, as
summarized in the model in Figure 7, ribosome deficiency
activates a mechanism that, through inhibition of transla-
tion elongation, slows down the synthesis of all proteins ex-

























Figure 7 Model of TOP mRNA regulation in response to ribosomal stress. TOP mRNAs are poorly translated (compared to non-TOP mRNAs) and
thus partly non-utilized because they are ‘weak’ competitors for translation initiation. In response to ribosomal stress, eEF2 is phosphorylated and the
elongation rate is reduced. As a consequence, competition at elongation is reduced, and some of the unused TOP mRNAs are recruited into polysomes
whereas more efficient non-TOP mRNAs cannot be recruited because they were already fully utilized. Therefore the synthesis of TOP mRNA-encoded
proteins is maintained approximately constant (the recruitment roughly compensates the decrease of elongation rate) whereas the synthesis of other cellular
proteins is reduced.
cept, e.g. RPs (whose mRNAs are recruited into polysomes
allowing their synthesis to be maintained even though the
overall elongation rate is slowed).
However, it may be that this regulation evolved simply to
preserve the synthesis of crucial cellular components in crit-
ical growth conditions. Although a comprehensive survey
of TOP mRNAs is not available, this group of messengers
encodes proteins which are obviously essential for the cell,
such as RPs and translation factors. The reason why other
components of the translation machinery (e.g. aminoacyl-
tRNA-synthetases, initiation factors) are not encoded by
TOP mRNAs is not clear. The presence of the TOP struc-
ture in at the 5′-end of the mRNAs for all RPs (with no
exceptions) and all translation elongation factors in verte-
brates (43,44) indicates that it has an important regulatory
function. It is intriguing that the synthesis of the main com-
ponents of the translation apparatus (RPs and elongation
factors) is regulated at the translational level. In addition,
we report here that TOP mRNAs are specifically sensitive
to alterations in the elongation rate. The fact that all elonga-
tion factors (but only a few among initiation and termina-
tion factors) are encoded by TOP mRNA strongly suggests
the operation of a regulatory loop affecting elongation fac-
tor expression. Based on the present data, this could be an
‘autoregulatory loop’ whereby impaired elongation rates,
which may result from inadequate levels of elongation fac-
tors, cause an increase in the translation of the mRNAs for
elongation factors in order to rectify this insufficiency.
The translational reprogramming we observed following
ribosomal stress could play a role in the pathological mech-
anism of Diamond-Blackfan Anemia (DBA). For instance,
alteration of balance between proteins encoded by ‘weak’
and ‘strong’ mRNAs could affect hematopoiesis.
A number of studies indicate that a defect in ribosome
synthesis causes the binding of some RPs to the ubiqui-
tin ligase MDM2 leading to a stabilization of p53 (45,46).
Which RPs are direct binders and therefore necessary for
the stress response, it is still debated (47,48). In any case,
our results may be consistent with this model. In fact, we
find that ribosomal stress, through inhibition of translation
elongation, favors the synthesis of all RPs including the pu-
tative binders to MDM2. It should be noted however that
depletion of all RPs tested, both binders (RPL11, RPS7)
and non-binders (RPS6, RPS19) caused a similar response
at the level of TOP mRNA recruitment. In addition, p53-
negative cells were also used in the experiments. Therefore
the phenomenon we describe does not appear to be directly
correlated with the RP-MDM2-p53 pathway.
It should be noted that our model suggests a rationale
for the intrinsically low translational efficiency of mRNAs
bearing the TOP sequence: it is a simple device to couple
the synthesis of certain proteins required for adequate ribo-
some production with ribosomal stress. In this respect, the
TOP sequence, similarly to some internal ribosomal entry
sites (IREs)or upstream open reading frames (uORF) (49),
represents a kind of cis-acting element necessary to preserve
the translation of specificmRNAs in particular ‘emergency’
circumstances. An important goal for future work is the
identification of the component(s) of the translational ap-
paratus that act as the ‘selectivity factor’ that confers the
selective control of 5′-TOPmRNAs by mTORC1 signaling.
A good candidate would be the cap-binding protein eIF4E
which, however, was seemingly excluded several years ago
(50), but suggested again more recently (51). Similarly, the
proposal that 4E-BP1 is a TOP mRNA regulator has been
the subject of conflicting reports (6,7). In addition, the pos-
sibility of some kind of specific TOP mRNA binding fac-
tor has been investigated over many years without conclu-
sive results (36). Therefore, the issue is still open with no
clear hypothesis. Two general possibilities are: (i) the ‘se-
lector’ is an unknown or uncharacterized component, such
as, for instance, an isoform of an initiation factor (eIF4E-2,
eIF4GII, etc.); (ii) more than one initiation factor partici-
pates in the ‘selection’ process, making their identification
more difficult.
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Finally, we think that the ‘weakness’ of TOP mRNAs,
coupled with specific changes in the balance between initi-
ation and elongation, could explain the ‘bimodal’ distribu-
tion of these mRNAs which was observed in the early stud-
ies: TOP mRNAs are either fully loaded onto polysomes
or stored as subpolysomal messenger ribonucleoprotein
(30,31). We think that the simultaneous modification of ini-
tiation and elongation rates could cause a change of the per-
centage of TOP mRNAs associated to polysomes without
altering polysome size.
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